The global cell surface marker detection market is expected
to reach USD 6.49 billion by 2022, according to a new report by Grand View
Research, Inc. This growth in demand can be attributed to rise in incidence of
oncology diseases and other cell-associated disorders.
Rapid introduction of advancements and
automations in clinical laboratories is a key factor affecting this industry.
Incorporation of novel algorithms pertaining to diagnosis and prognosis of
chronic disorders is expected to fuel demand of this market in the coming
years.
Requirement of solutions for data
handling and interpretation of clinical conditions based on obtained results
are anticipated to enhance potential for R&D in this sector, consequently
driving market growth over the forecast period.
Browse full research report on Cell Surface Marker Detection Market: https://www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market
Further key findings from the report suggest:
- Flow cytometry devices accounted for over 70% of the revenue
generated in the industry for 2014. This large share can be attributed to
the growing advancement in these instruments such as enhancement in
efficiency and resolution of fluorescence-based cytometric detectors.
Furthermore, presence of large product portfolio of different industry
players operating in cytometry is responsible for large market share of
this technique.
- Disease diagnosis and identification accounted for over 50%
of the revenue generated in the market for 2014. High incidence rate of
cell-associated disorders and oncology diseases that need to be treated in
order to curb the mortality rate are the major drivers for growth of this
segment.
- Determination of novel drug targets and development of
biopharmaceuticals for prognosis of chronic diseases is anticipated to
propel growth of research and drug discovery sub-segment in the coming
years. With expected development of this segment, the sector will witness
lucrative growth over the forecast period.
- North America accounted for the largest share of this sector
for 2014, as there are is significantly high number of research and
development projects ongoing in the region related to cytological investigation
for proteomics, genomics, and drug and vaccine development. Growing need
for biopharmaceuticals is also anticipated to fuel regional growth.
- North America dominated the industry in 2014, with revenue
estimated at USD 999.0 million. Presence of sophisticated healthcare
infrastructure and favorable government initiatives with respect to
analytical techniques and their applications for disease diagnosis and
drug development are some key factors likely to drive growth.
- Asia Pacific is expected to witness lucrative growth from
2015 to 2022 due to the presence of high-unmet medical needs coupled with
rapidly rising healthcare R&D investment and growing medical
expenditures in emerging economies of India and China
- Key participants of the cell surface marker detection
industry include Siemens Healthcare, Nihon Kohden Corporation, Sartorius,
Janssen Diagnostics Inc., Grifols SA, Thermo Fisher Scientific, BioRad
Laboratories Inc., and F. Hoffman La Roche Ltd.
- These participants are involved in R&D for production of
cell-specific antibodies and collaborations with smaller entities
operating in the market as well as with academic research laboratories in
order to maintain their market position and enter the untapped market
regions
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market/request/rs1
Grand View Research has segmented cell surface marker detection
market on the basis of product, application, and region:
Cell Surface Marker Detection Product Outlook (Market Revenue in
USD Million, 2012 - 2022 )
- Flow
Cytometry
- Hematology
Analyzers
- Reagents
& Kits
Cell Surface Marker Detection Application Outlook (Market Revenue
in USD Million, 2012 - 2022 )
- Disease
Diagnosis & Identification
- Research
& Drug Discovery
- Others
Cell Surface Marker Detection Regional Outlook (Market Revenue in
USD Million, 2012 - 2022 )
- North
America
- Europe
- Asia
Pacific
- RoW
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment